vs
Amarin Corp plc（AMRN）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
PDF SOLUTIONS INC的季度营收约是Amarin Corp plc的1.4倍（$62.4M vs $45.1M），PDF SOLUTIONS INC净利率更高（-0.1% vs -23.3%，领先23.2%），PDF SOLUTIONS INC同比增速更快（24.6% vs 7.0%），过去两年PDF SOLUTIONS INC的营收复合增速更高（22.9% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
AMRN vs PDFS — 直观对比
营收规模更大
PDFS
是对方的1.4倍
$45.1M
营收增速更快
PDFS
高出17.6%
7.0%
净利率更高
PDFS
高出23.2%
-23.3%
两年增速更快
PDFS
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $62.4M |
| 净利润 | $-10.5M | $-48.0K |
| 毛利率 | — | 72.9% |
| 营业利润率 | 35.5% | 5.5% |
| 净利率 | -23.3% | -0.1% |
| 营收同比 | 7.0% | 24.6% |
| 净利润同比 | 33.0% | -108.9% |
| 每股收益（稀释后） | — | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNPDFS
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $62.4M | ||
| Q3 25 | $49.7M | $57.1M | ||
| Q2 25 | $72.7M | $51.7M | ||
| Q1 25 | $42.0M | $47.8M | ||
| Q4 24 | $62.3M | $50.1M | ||
| Q3 24 | $42.3M | $46.4M | ||
| Q2 24 | $67.5M | $41.7M |
净利润AMRNPDFS
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-48.0K | ||
| Q3 25 | $-7.7M | $1.3M | ||
| Q2 25 | $-14.1M | $1.1M | ||
| Q1 25 | $-15.7M | $-3.0M | ||
| Q4 24 | $-48.6M | $539.0K | ||
| Q3 24 | $-25.1M | $2.2M | ||
| Q2 24 | $1.5M | $1.7M |
毛利率AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 72.9% | ||
| Q3 25 | 44.7% | 72.3% | ||
| Q2 25 | 69.2% | 71.2% | ||
| Q1 25 | 59.8% | 72.9% | ||
| Q4 24 | -15.4% | 68.3% | ||
| Q3 24 | 38.5% | 73.1% | ||
| Q2 24 | 63.4% | 70.6% |
营业利润率AMRNPDFS
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 5.5% | ||
| Q3 25 | -22.4% | 8.5% | ||
| Q2 25 | -22.0% | 2.2% | ||
| Q1 25 | -39.9% | -7.4% | ||
| Q4 24 | -84.3% | 1.0% | ||
| Q3 24 | -59.5% | 4.6% | ||
| Q2 24 | -0.8% | 0.6% |
净利率AMRNPDFS
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -0.1% | ||
| Q3 25 | -15.6% | 2.3% | ||
| Q2 25 | -19.4% | 2.2% | ||
| Q1 25 | -37.4% | -6.3% | ||
| Q4 24 | -78.0% | 1.1% | ||
| Q3 24 | -59.4% | 4.8% | ||
| Q2 24 | 2.3% | 4.1% |
每股收益（稀释后）AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $-0.02 | $0.03 | ||
| Q2 25 | $-0.03 | $0.03 | ||
| Q1 25 | $-0.04 | $-0.08 | ||
| Q4 24 | $-0.12 | $0.01 | ||
| Q3 24 | $-0.06 | $0.06 | ||
| Q2 24 | $0.00 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $42.2M |
| 总债务越低越好 | — | $67.0M |
| 股东权益账面价值 | — | $271.0M |
| 总资产 | $645.8M | $418.7M |
| 负债/权益比越低杠杆越低 | — | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资AMRNPDFS
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $42.2M | ||
| Q3 25 | $286.6M | $35.9M | ||
| Q2 25 | $298.7M | $40.4M | ||
| Q1 25 | $281.8M | $54.1M | ||
| Q4 24 | $294.2M | $114.9M | ||
| Q3 24 | $305.7M | $120.2M | ||
| Q2 24 | $306.7M | $117.9M |
总债务AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | $67.0M | ||
| Q3 25 | — | $67.6M | ||
| Q2 25 | — | $68.1M | ||
| Q1 25 | — | $68.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $271.0M | ||
| Q3 25 | $458.9M | $264.4M | ||
| Q2 25 | $464.9M | $257.5M | ||
| Q1 25 | $473.7M | $249.0M | ||
| Q4 24 | $486.2M | $246.0M | ||
| Q3 24 | $531.4M | $240.5M | ||
| Q2 24 | $551.9M | $232.2M |
总资产AMRNPDFS
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $418.7M | ||
| Q3 25 | $659.8M | $406.4M | ||
| Q2 25 | $670.1M | $391.1M | ||
| Q1 25 | $655.7M | $390.0M | ||
| Q4 24 | $685.3M | $315.3M | ||
| Q3 24 | $750.6M | $307.4M | ||
| Q2 24 | $799.9M | $298.0M |
负债/权益比AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $17.3M |
| 自由现金流经营现金流 - 资本支出 | — | $7.5M |
| 自由现金流率自由现金流/营收 | — | 12.1% |
| 资本支出强度资本支出/营收 | — | 15.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.6M |
8季度趋势，按日历期对齐
经营现金流AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $17.3M | ||
| Q3 25 | $-12.7M | $3.3M | ||
| Q2 25 | $16.6M | $-5.2M | ||
| Q1 25 | $-12.5M | $8.6M | ||
| Q4 24 | $-13.3M | $1.6M | ||
| Q3 24 | $-2.4M | $9.3M | ||
| Q2 24 | $-2.7M | $684.0K |
自由现金流AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | — | $-13.8M | ||
| Q1 25 | — | $535.0K | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $-4.6M |
自由现金流率AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | -5.1% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | -8.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | -11.1% |
资本支出强度AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 12.8% |
现金转化率AMRNPDFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | -4.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | — | 4.20× | ||
| Q2 24 | -1.81× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
